{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:26:28Z","timestamp":1779114388133,"version":"3.51.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cholangiocarcinomas have a poor prognosis, and resection is the only curative-intent treatment. We examined time trends in mortality risk after resection in a nationwide Danish cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We identified all Danish citizens diagnosed with cholangiocarcinoma in 2004\u20132022 who subsequently underwent liver resection, biliary tract resection, or a combination of the two. We computed the proportions of patients who received downstaging or adjuvant chemotherapy, and we estimated age- and sex-adjusted mortality risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Between 2004 and 2022, 611 patients with cholangiocarcinoma underwent resection (13% of 4572 patients with cholangiocarcinoma). The proportion who underwent resection increased from 9% in 2004\u20132012 to 16% in 2018\u20132022, the median age of resected patients rose from 65 to 69 years, and the proportion with comorbidities increased from 17% to 28%. In patients who underwent liver resection, the proportion who had received downstaging chemotherapy increased from &lt;7% in 2004\u20132012 to 12% (8\u201320), and the proportion who received adjuvant chemotherapy increased from 27% (18\u201339) in 2004\u20132012 to 49% (40\u201358) in 2018\u20132022. Despite the increasing use of chemotherapy before and after liver resection, age- and sex-adjusted mortality remained essentially the same, with 1-year mortality ranging from 14% to 20% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value = 0.37). In patients who underwent biliary tract resection, only 3% received downstaging chemotherapy, but the proportion who received adjuvant therapy increased from 17% (10\u201329) in 2004\u20132012 to 59% (48\u201368) in 2018\u20132022. Even so, these patients\u2019 age- and sex-adjusted mortality remained stable (1-year mortality ranging from 19% to 24%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value = 0.34).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The proportion of patients with cholangiocarcinoma who underwent liver or biliary tract resection increased, and more patients received downstaging chemotherapy and adjuvant chemotherapy. Nonetheless, age- and sex-adjusted mortality risks remained constant. The explanations for this pattern are unclear but likely involve changing patient characteristics other than age and sex.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003329","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T14:00:10Z","timestamp":1757080810000},"page":"1048-1056","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cholangiocarcinoma in Denmark: time trends in mortality following resection"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5137-7268","authenticated-orcid":false,"given":"Morten D.","family":"Jensen","sequence":"first","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-9356","authenticated-orcid":false,"given":"Joe","family":"West","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK"},{"name":"NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-1204","authenticated-orcid":false,"given":"Britta","family":"Weber","sequence":"additional","affiliation":[{"name":"Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3749-3529","authenticated-orcid":false,"given":"Alice","family":"Markussen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Copenhagen University Hospital\u2013Herlev and Gentofte, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7580-8037","authenticated-orcid":false,"given":"Frank V.","family":"Mortensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Department of Surgical Gastroenterology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-1430","authenticated-orcid":false,"given":"Peter","family":"Jepsen","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"R1-20260518","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12957-024-03596-y","article-title":"Resectability and survival outcome in real world practice of 720 cholangiocarcinoma patients: intrahepatic, perihilar and distal cholangiocarcinoma","volume":"22","author":"Sarkhampee","year":"2024","journal-title":"World J Surg Oncol"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"2666\u201378","DOI":"10.1002\/cncr.32803","article-title":"Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012","volume":"126","author":"Florio","year":"2020","journal-title":"Cancer"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"70","DOI":"10.21037\/cco-23-144","article-title":"Advancements in cholangiocarcinoma: evolving strategies for diagnosis, treatment, and palliation over three decades","volume":"13","author":"Elias","year":"2024","journal-title":"Chin Clin Oncol"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"101493","DOI":"10.1016\/j.jhepr.2025.101493","article-title":"Cholangiocarcinoma in Denmark: time-trends in incidence and mortality (online ahead of print)","volume":"7","author":"Jensen","year":"2025","journal-title":"JHEP Rep"},{"key":"R5-20260518","doi-asserted-by":"crossref","first-page":"1048\u201355","DOI":"10.1080\/0284186X.2019.1590634","article-title":"Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study","volume":"58","author":"Strijker","year":"2019","journal-title":"Acta Oncol"},{"key":"R6-20260518","article-title":"Revised strengthening the reporting of cohort, Cross-Sectional and Case-Control Studies in Surgery (STROCSS) Guideline: an Update for the Age of Artificial Intelligence","volume":"2","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R7-20260518","first-page":"449\u201390","article-title":"The Danish national patient registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"R8-20260518","doi-asserted-by":"crossref","first-page":"42\u201345","DOI":"10.1177\/1403494810393562","article-title":"The Danish cancer registry","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scandinavian J Public Health"},{"key":"R9-20260518","doi-asserted-by":"crossref","first-page":"22\u201325","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scandinavian J Public Health"},{"key":"R12-20260518","doi-asserted-by":"crossref","first-page":"1130\u201339","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"373\u201383","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R14-20260518","doi-asserted-by":"crossref","first-page":"663\u201373","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"R16-20260518","doi-asserted-by":"crossref","first-page":"572\u201380","DOI":"10.1080\/00365521.2025.2487539","article-title":"Non-liver comorbidity in patients with hepatocellular carcinoma and curative treatments \u2013 a Swedish national registry study","volume":"60","author":"Sternby Eilard","year":"2025","journal-title":"Scand J Gastroenterol"},{"key":"R17-20260518","doi-asserted-by":"crossref","first-page":"2\u201314","DOI":"10.23838\/pfm.2024.00191","article-title":"The use of Charlson comorbidity index for observational studies using administrative data in Korea","volume":"9","author":"Shin","year":"2025","journal-title":"Precis Future Med"},{"key":"R18-20260518","doi-asserted-by":"crossref","first-page":"1337\u201345","DOI":"10.14309\/ajg.0000000000002677","article-title":"Population-based study of alcohol-related liver disease in England in 2001-2018: influence of socioeconomic position","volume":"119","author":"Askgaard","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"R20-20260518","doi-asserted-by":"crossref","first-page":"1273\u201381","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"R23-20260518","doi-asserted-by":"crossref","first-page":"1604\u201308","DOI":"10.1056\/NEJM198506203122504","article-title":"The will rogers phenomenon","volume":"312","author":"Feinstein","year":"1985","journal-title":"N Engl J Med"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:20:51Z","timestamp":1779110451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003329","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"2025-05-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}